• レポートコード:QY2207E02131 • 出版社/出版日:QYResearch / 2022年7月 • レポート形態:英文、PDF、126ページ • 納品方法:Eメール(納期:3日) • 産業分類:化学&材料 |
Single User | ¥735,000 (USD4,900) | ▷ お問い合わせ |
Multi User | ¥1,102,500 (USD7,350) | ▷ お問い合わせ |
Enterprise License | ¥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のブタヘパリンナトリウムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にブタヘパリンナトリウムの世界市場のxxx%を占める「純度≥99%」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「注射液」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。 中国のブタヘパリンナトリウムの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのブタヘパリンナトリウム市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのブタヘパリンナトリウム市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。 ブタヘパリンナトリウムのグローバル主要メーカーには、Pfizer、Bioibérica、OPOCRIN、Aspen、Suanfarma、Kraeber & Co GmbH、Hepartex、Hepalink Pharmaceutical Group、Nanjing King-friend、Haike Group、Cisen Pharmaceutical、Qianhong Biopharma、Xinbai Pharmaceuticals、Yino Pharma、Deebio Pharmaceutical、Tianjin Chasesun Pharmaceutical、Haike Group、Sheelian Pharmaceutical、Erye Pharmaceutical、Wanbang Pharmaceutical、Qingdao Kangyuan Pharmaceutical、CSBIO、Dongcheng Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。 ブタヘパリンナトリウム市場は、種類と用途によって区分されます。世界のブタヘパリンナトリウム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 純度≥99%、純度≥99.5% 【用途別セグメント】 注射液、軟膏、その他 【掲載地域】 北米:アメリカ、カナダ ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米:メキシコ、ブラジル、アルゼンチン 中東・アフリカ:トルコ、サウジアラビア、UAE 【目次(一部)】 ・調査の範囲 - ブタヘパリンナトリウム製品概要 - 種類別市場(純度≥99%、純度≥99.5%) - 用途別市場(注射液、軟膏、その他) - 調査の目的 ・エグゼクティブサマリー - 世界のブタヘパリンナトリウム販売量予測2017-2028 - 世界のブタヘパリンナトリウム売上予測2017-2028 - ブタヘパリンナトリウムの地域別販売量 - ブタヘパリンナトリウムの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ブタヘパリンナトリウム販売量 - 主要メーカー別ブタヘパリンナトリウム売上 - 主要メーカー別ブタヘパリンナトリウム価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模(純度≥99%、純度≥99.5%) - ブタヘパリンナトリウムの種類別販売量 - ブタヘパリンナトリウムの種類別売上 - ブタヘパリンナトリウムの種類別価格 ・用途別市場規模(注射液、軟膏、その他) - ブタヘパリンナトリウムの用途別販売量 - ブタヘパリンナトリウムの用途別売上 - ブタヘパリンナトリウムの用途別価格 ・北米市場 - 北米のブタヘパリンナトリウム市場規模(種類別、用途別) - 主要国別のブタヘパリンナトリウム市場規模(アメリカ、カナダ) ・ヨーロッパ市場 - ヨーロッパのブタヘパリンナトリウム市場規模(種類別、用途別) - 主要国別のブタヘパリンナトリウム市場規模(ドイツ、フランス、イギリス、イタリア、ロシア) ・アジア太平洋市場 - アジア太平洋のブタヘパリンナトリウム市場規模(種類別、用途別) - 主要国別のブタヘパリンナトリウム市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア) ・中南米市場 - 中南米のブタヘパリンナトリウム市場規模(種類別、用途別) - 主要国別のブタヘパリンナトリウム市場規模(メキシコ、ブラジル、アルゼンチン) ・中東・アフリカ市場 - 中東・アフリカのブタヘパリンナトリウム市場規模(種類別、用途別) - 主要国別のブタヘパリンナトリウム市場規模(トルコ、サウジアラビア) ・企業情報 Pfizer、Bioibérica、OPOCRIN、Aspen、Suanfarma、Kraeber & Co GmbH、Hepartex、Hepalink Pharmaceutical Group、Nanjing King-friend、Haike Group、Cisen Pharmaceutical、Qianhong Biopharma、Xinbai Pharmaceuticals、Yino Pharma、Deebio Pharmaceutical、Tianjin Chasesun Pharmaceutical、Haike Group、Sheelian Pharmaceutical、Erye Pharmaceutical、Wanbang Pharmaceutical、Qingdao Kangyuan Pharmaceutical、CSBIO、Dongcheng Pharmaceutical ・産業チェーン及び販売チャネル分析 - ブタヘパリンナトリウムの産業チェーン分析 - ブタヘパリンナトリウムの原材料 - ブタヘパリンナトリウムの生産プロセス - ブタヘパリンナトリウムの販売及びマーケティング - ブタヘパリンナトリウムの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ブタヘパリンナトリウムの産業動向 - ブタヘパリンナトリウムのマーケットドライバー - ブタヘパリンナトリウムの課題 - ブタヘパリンナトリウムの阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Porcine Heparin Sodium Market
Due to the COVID-19 pandemic, the global Porcine Heparin Sodium market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity ≥99% accounting for % of the Porcine Heparin Sodium global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Injection Solution segment is altered to an % CAGR throughout this forecast period.
China Porcine Heparin Sodium market size is valued at US$ million in 2021, while the US and Europe Porcine Heparin Sodium are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Porcine Heparin Sodium landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Porcine Heparin Sodium include Pfizer, Bioibérica, OPOCRIN, Aspen, Suanfarma, Kraeber & Co GmbH, Hepartex, Hepalink Pharmaceutical Group and Nanjing King-friend, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Porcine Heparin Sodium capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Porcine Heparin Sodium by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Porcine Heparin Sodium Scope and Segment
Porcine Heparin Sodium market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Porcine Heparin Sodium market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity ≥99%
Purity ≥99.5%
Segment by Application
Injection Solution
Ointment
Others
By Company
Pfizer
Bioibérica
OPOCRIN
Aspen
Suanfarma
Kraeber & Co GmbH
Hepartex
Hepalink Pharmaceutical Group
Nanjing King-friend
Haike Group
Cisen Pharmaceutical
Qianhong Biopharma
Xinbai Pharmaceuticals
Yino Pharma
Deebio Pharmaceutical
Tianjin Chasesun Pharmaceutical
Haike Group
Sheelian Pharmaceutical
Erye Pharmaceutical
Wanbang Pharmaceutical
Qingdao Kangyuan Pharmaceutical
CSBIO
Dongcheng Pharmaceutical
Production by Region
North America
Europe
China
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Porcine Heparin Sodium Product Introduction
1.2 Market by Type
1.2.1 Global Porcine Heparin Sodium Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity ≥99%
1.2.3 Purity ≥99.5%
1.3 Market by Application
1.3.1 Global Porcine Heparin Sodium Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Injection Solution
1.3.3 Ointment
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Porcine Heparin Sodium Production
2.1 Global Porcine Heparin Sodium Production Capacity (2017-2028)
2.2 Global Porcine Heparin Sodium Production by Region: 2017 VS 2021 VS 2028
2.3 Global Porcine Heparin Sodium Production by Region
2.3.1 Global Porcine Heparin Sodium Historic Production by Region (2017-2022)
2.3.2 Global Porcine Heparin Sodium Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
3 Global Porcine Heparin Sodium Sales in Volume & Value Estimates and Forecasts
3.1 Global Porcine Heparin Sodium Sales Estimates and Forecasts 2017-2028
3.2 Global Porcine Heparin Sodium Revenue Estimates and Forecasts 2017-2028
3.3 Global Porcine Heparin Sodium Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Porcine Heparin Sodium Sales by Region
3.4.1 Global Porcine Heparin Sodium Sales by Region (2017-2022)
3.4.2 Global Sales Porcine Heparin Sodium by Region (2023-2028)
3.5 Global Porcine Heparin Sodium Revenue by Region
3.5.1 Global Porcine Heparin Sodium Revenue by Region (2017-2022)
3.5.2 Global Porcine Heparin Sodium Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Porcine Heparin Sodium Production Capacity by Manufacturers
4.2 Global Porcine Heparin Sodium Sales by Manufacturers
4.2.1 Global Porcine Heparin Sodium Sales by Manufacturers (2017-2022)
4.2.2 Global Porcine Heparin Sodium Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Porcine Heparin Sodium in 2021
4.3 Global Porcine Heparin Sodium Revenue by Manufacturers
4.3.1 Global Porcine Heparin Sodium Revenue by Manufacturers (2017-2022)
4.3.2 Global Porcine Heparin Sodium Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Porcine Heparin Sodium Revenue in 2021
4.4 Global Porcine Heparin Sodium Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Porcine Heparin Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Porcine Heparin Sodium Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Porcine Heparin Sodium Sales by Type
5.1.1 Global Porcine Heparin Sodium Historical Sales by Type (2017-2022)
5.1.2 Global Porcine Heparin Sodium Forecasted Sales by Type (2023-2028)
5.1.3 Global Porcine Heparin Sodium Sales Market Share by Type (2017-2028)
5.2 Global Porcine Heparin Sodium Revenue by Type
5.2.1 Global Porcine Heparin Sodium Historical Revenue by Type (2017-2022)
5.2.2 Global Porcine Heparin Sodium Forecasted Revenue by Type (2023-2028)
5.2.3 Global Porcine Heparin Sodium Revenue Market Share by Type (2017-2028)
5.3 Global Porcine Heparin Sodium Price by Type
5.3.1 Global Porcine Heparin Sodium Price by Type (2017-2022)
5.3.2 Global Porcine Heparin Sodium Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Porcine Heparin Sodium Sales by Application
6.1.1 Global Porcine Heparin Sodium Historical Sales by Application (2017-2022)
6.1.2 Global Porcine Heparin Sodium Forecasted Sales by Application (2023-2028)
6.1.3 Global Porcine Heparin Sodium Sales Market Share by Application (2017-2028)
6.2 Global Porcine Heparin Sodium Revenue by Application
6.2.1 Global Porcine Heparin Sodium Historical Revenue by Application (2017-2022)
6.2.2 Global Porcine Heparin Sodium Forecasted Revenue by Application (2023-2028)
6.2.3 Global Porcine Heparin Sodium Revenue Market Share by Application (2017-2028)
6.3 Global Porcine Heparin Sodium Price by Application
6.3.1 Global Porcine Heparin Sodium Price by Application (2017-2022)
6.3.2 Global Porcine Heparin Sodium Price Forecast by Application (2023-2028)
7 North America
7.1 North America Porcine Heparin Sodium Market Size by Type
7.1.1 North America Porcine Heparin Sodium Sales by Type (2017-2028)
7.1.2 North America Porcine Heparin Sodium Revenue by Type (2017-2028)
7.2 North America Porcine Heparin Sodium Market Size by Application
7.2.1 North America Porcine Heparin Sodium Sales by Application (2017-2028)
7.2.2 North America Porcine Heparin Sodium Revenue by Application (2017-2028)
7.3 North America Porcine Heparin Sodium Sales by Country
7.3.1 North America Porcine Heparin Sodium Sales by Country (2017-2028)
7.3.2 North America Porcine Heparin Sodium Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Porcine Heparin Sodium Market Size by Type
8.1.1 Europe Porcine Heparin Sodium Sales by Type (2017-2028)
8.1.2 Europe Porcine Heparin Sodium Revenue by Type (2017-2028)
8.2 Europe Porcine Heparin Sodium Market Size by Application
8.2.1 Europe Porcine Heparin Sodium Sales by Application (2017-2028)
8.2.2 Europe Porcine Heparin Sodium Revenue by Application (2017-2028)
8.3 Europe Porcine Heparin Sodium Sales by Country
8.3.1 Europe Porcine Heparin Sodium Sales by Country (2017-2028)
8.3.2 Europe Porcine Heparin Sodium Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Porcine Heparin Sodium Market Size by Type
9.1.1 Asia Pacific Porcine Heparin Sodium Sales by Type (2017-2028)
9.1.2 Asia Pacific Porcine Heparin Sodium Revenue by Type (2017-2028)
9.2 Asia Pacific Porcine Heparin Sodium Market Size by Application
9.2.1 Asia Pacific Porcine Heparin Sodium Sales by Application (2017-2028)
9.2.2 Asia Pacific Porcine Heparin Sodium Revenue by Application (2017-2028)
9.3 Asia Pacific Porcine Heparin Sodium Sales by Region
9.3.1 Asia Pacific Porcine Heparin Sodium Sales by Region (2017-2028)
9.3.2 Asia Pacific Porcine Heparin Sodium Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Porcine Heparin Sodium Market Size by Type
10.1.1 Latin America Porcine Heparin Sodium Sales by Type (2017-2028)
10.1.2 Latin America Porcine Heparin Sodium Revenue by Type (2017-2028)
10.2 Latin America Porcine Heparin Sodium Market Size by Application
10.2.1 Latin America Porcine Heparin Sodium Sales by Application (2017-2028)
10.2.2 Latin America Porcine Heparin Sodium Revenue by Application (2017-2028)
10.3 Latin America Porcine Heparin Sodium Sales by Country
10.3.1 Latin America Porcine Heparin Sodium Sales by Country (2017-2028)
10.3.2 Latin America Porcine Heparin Sodium Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Porcine Heparin Sodium Market Size by Type
11.1.1 Middle East and Africa Porcine Heparin Sodium Sales by Type (2017-2028)
11.1.2 Middle East and Africa Porcine Heparin Sodium Revenue by Type (2017-2028)
11.2 Middle East and Africa Porcine Heparin Sodium Market Size by Application
11.2.1 Middle East and Africa Porcine Heparin Sodium Sales by Application (2017-2028)
11.2.2 Middle East and Africa Porcine Heparin Sodium Revenue by Application (2017-2028)
11.3 Middle East and Africa Porcine Heparin Sodium Sales by Country
11.3.1 Middle East and Africa Porcine Heparin Sodium Sales by Country (2017-2028)
11.3.2 Middle East and Africa Porcine Heparin Sodium Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Overview
12.1.3 Pfizer Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Pfizer Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Pfizer Recent Developments
12.2 Bioibérica
12.2.1 Bioibérica Corporation Information
12.2.2 Bioibérica Overview
12.2.3 Bioibérica Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Bioibérica Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Bioibérica Recent Developments
12.3 OPOCRIN
12.3.1 OPOCRIN Corporation Information
12.3.2 OPOCRIN Overview
12.3.3 OPOCRIN Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 OPOCRIN Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 OPOCRIN Recent Developments
12.4 Aspen
12.4.1 Aspen Corporation Information
12.4.2 Aspen Overview
12.4.3 Aspen Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Aspen Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Aspen Recent Developments
12.5 Suanfarma
12.5.1 Suanfarma Corporation Information
12.5.2 Suanfarma Overview
12.5.3 Suanfarma Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Suanfarma Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Suanfarma Recent Developments
12.6 Kraeber & Co GmbH
12.6.1 Kraeber & Co GmbH Corporation Information
12.6.2 Kraeber & Co GmbH Overview
12.6.3 Kraeber & Co GmbH Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Kraeber & Co GmbH Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Kraeber & Co GmbH Recent Developments
12.7 Hepartex
12.7.1 Hepartex Corporation Information
12.7.2 Hepartex Overview
12.7.3 Hepartex Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Hepartex Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Hepartex Recent Developments
12.8 Hepalink Pharmaceutical Group
12.8.1 Hepalink Pharmaceutical Group Corporation Information
12.8.2 Hepalink Pharmaceutical Group Overview
12.8.3 Hepalink Pharmaceutical Group Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Hepalink Pharmaceutical Group Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Hepalink Pharmaceutical Group Recent Developments
12.9 Nanjing King-friend
12.9.1 Nanjing King-friend Corporation Information
12.9.2 Nanjing King-friend Overview
12.9.3 Nanjing King-friend Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Nanjing King-friend Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Nanjing King-friend Recent Developments
12.10 Haike Group
12.10.1 Haike Group Corporation Information
12.10.2 Haike Group Overview
12.10.3 Haike Group Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Haike Group Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Haike Group Recent Developments
12.11 Cisen Pharmaceutical
12.11.1 Cisen Pharmaceutical Corporation Information
12.11.2 Cisen Pharmaceutical Overview
12.11.3 Cisen Pharmaceutical Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Cisen Pharmaceutical Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Cisen Pharmaceutical Recent Developments
12.12 Qianhong Biopharma
12.12.1 Qianhong Biopharma Corporation Information
12.12.2 Qianhong Biopharma Overview
12.12.3 Qianhong Biopharma Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Qianhong Biopharma Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Qianhong Biopharma Recent Developments
12.13 Xinbai Pharmaceuticals
12.13.1 Xinbai Pharmaceuticals Corporation Information
12.13.2 Xinbai Pharmaceuticals Overview
12.13.3 Xinbai Pharmaceuticals Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Xinbai Pharmaceuticals Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Xinbai Pharmaceuticals Recent Developments
12.14 Yino Pharma
12.14.1 Yino Pharma Corporation Information
12.14.2 Yino Pharma Overview
12.14.3 Yino Pharma Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 Yino Pharma Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Yino Pharma Recent Developments
12.15 Deebio Pharmaceutical
12.15.1 Deebio Pharmaceutical Corporation Information
12.15.2 Deebio Pharmaceutical Overview
12.15.3 Deebio Pharmaceutical Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.15.4 Deebio Pharmaceutical Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Deebio Pharmaceutical Recent Developments
12.16 Tianjin Chasesun Pharmaceutical
12.16.1 Tianjin Chasesun Pharmaceutical Corporation Information
12.16.2 Tianjin Chasesun Pharmaceutical Overview
12.16.3 Tianjin Chasesun Pharmaceutical Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.16.4 Tianjin Chasesun Pharmaceutical Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 Tianjin Chasesun Pharmaceutical Recent Developments
12.17 Haike Group
12.17.1 Haike Group Corporation Information
12.17.2 Haike Group Overview
12.17.3 Haike Group Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.17.4 Haike Group Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.17.5 Haike Group Recent Developments
12.18 Sheelian Pharmaceutical
12.18.1 Sheelian Pharmaceutical Corporation Information
12.18.2 Sheelian Pharmaceutical Overview
12.18.3 Sheelian Pharmaceutical Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.18.4 Sheelian Pharmaceutical Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.18.5 Sheelian Pharmaceutical Recent Developments
12.19 Erye Pharmaceutical
12.19.1 Erye Pharmaceutical Corporation Information
12.19.2 Erye Pharmaceutical Overview
12.19.3 Erye Pharmaceutical Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.19.4 Erye Pharmaceutical Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.19.5 Erye Pharmaceutical Recent Developments
12.20 Wanbang Pharmaceutical
12.20.1 Wanbang Pharmaceutical Corporation Information
12.20.2 Wanbang Pharmaceutical Overview
12.20.3 Wanbang Pharmaceutical Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.20.4 Wanbang Pharmaceutical Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.20.5 Wanbang Pharmaceutical Recent Developments
12.21 Qingdao Kangyuan Pharmaceutical
12.21.1 Qingdao Kangyuan Pharmaceutical Corporation Information
12.21.2 Qingdao Kangyuan Pharmaceutical Overview
12.21.3 Qingdao Kangyuan Pharmaceutical Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.21.4 Qingdao Kangyuan Pharmaceutical Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.21.5 Qingdao Kangyuan Pharmaceutical Recent Developments
12.22 CSBIO
12.22.1 CSBIO Corporation Information
12.22.2 CSBIO Overview
12.22.3 CSBIO Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.22.4 CSBIO Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.22.5 CSBIO Recent Developments
12.23 Dongcheng Pharmaceutical
12.23.1 Dongcheng Pharmaceutical Corporation Information
12.23.2 Dongcheng Pharmaceutical Overview
12.23.3 Dongcheng Pharmaceutical Porcine Heparin Sodium Sales, Price, Revenue and Gross Margin (2017-2022)
12.23.4 Dongcheng Pharmaceutical Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
12.23.5 Dongcheng Pharmaceutical Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Porcine Heparin Sodium Industry Chain Analysis
13.2 Porcine Heparin Sodium Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Porcine Heparin Sodium Production Mode & Process
13.4 Porcine Heparin Sodium Sales and Marketing
13.4.1 Porcine Heparin Sodium Sales Channels
13.4.2 Porcine Heparin Sodium Distributors
13.5 Porcine Heparin Sodium Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Porcine Heparin Sodium Industry Trends
14.2 Porcine Heparin Sodium Market Drivers
14.3 Porcine Heparin Sodium Market Challenges
14.4 Porcine Heparin Sodium Market Restraints
15 Key Finding in The Global Porcine Heparin Sodium Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Porcine Heparin Sodium Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Purity ≥99%
Table 3. Major Manufacturers of Purity ≥99.5%
Table 4. Global Porcine Heparin Sodium Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Porcine Heparin Sodium Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 6. Global Porcine Heparin Sodium Production by Region (2017-2022) & (Tons)
Table 7. Global Porcine Heparin Sodium Production Market Share by Region (2017-2022)
Table 8. Global Porcine Heparin Sodium Production by Region (2023-2028) & (Tons)
Table 9. Global Porcine Heparin Sodium Production Market Share by Region (2023-2028)
Table 10. Global Porcine Heparin Sodium Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Porcine Heparin Sodium Sales by Region (2017-2022) & (Tons)
Table 12. Global Porcine Heparin Sodium Sales Market Share by Region (2017-2022)
Table 13. Global Porcine Heparin Sodium Sales by Region (2023-2028) & (Tons)
Table 14. Global Porcine Heparin Sodium Sales Market Share by Region (2023-2028)
Table 15. Global Porcine Heparin Sodium Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Porcine Heparin Sodium Revenue Market Share by Region (2017-2022)
Table 17. Global Porcine Heparin Sodium Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Porcine Heparin Sodium Revenue Market Share by Region (2023-2028)
Table 19. Global Porcine Heparin Sodium Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 20. Global Porcine Heparin Sodium Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Porcine Heparin Sodium Sales by Manufacturers (2017-2022) & (Tons)
Table 22. Global Porcine Heparin Sodium Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Porcine Heparin Sodium Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Porcine Heparin Sodium Revenue Share by Manufacturers (2017-2022)
Table 25. Porcine Heparin Sodium Price by Manufacturers 2017-2022 (US$/Kg)
Table 26. Global Porcine Heparin Sodium Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Porcine Heparin Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Porcine Heparin Sodium as of 2021)
Table 28. Porcine Heparin Sodium Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Porcine Heparin Sodium Product Offered
Table 30. Date of Manufacturers Enter into Porcine Heparin Sodium Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Porcine Heparin Sodium Sales by Type (2017-2022) & (Tons)
Table 33. Global Porcine Heparin Sodium Sales by Type (2023-2028) & (Tons)
Table 34. Global Porcine Heparin Sodium Sales Share by Type (2017-2022)
Table 35. Global Porcine Heparin Sodium Sales Share by Type (2023-2028)
Table 36. Global Porcine Heparin Sodium Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global Porcine Heparin Sodium Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global Porcine Heparin Sodium Revenue Share by Type (2017-2022)
Table 39. Global Porcine Heparin Sodium Revenue Share by Type (2023-2028)
Table 40. Porcine Heparin Sodium Price by Type (2017-2022) & (US$/Kg)
Table 41. Global Porcine Heparin Sodium Price Forecast by Type (2023-2028) & (US$/Kg)
Table 42. Global Porcine Heparin Sodium Sales by Application (2017-2022) & (Tons)
Table 43. Global Porcine Heparin Sodium Sales by Application (2023-2028) & (Tons)
Table 44. Global Porcine Heparin Sodium Sales Share by Application (2017-2022)
Table 45. Global Porcine Heparin Sodium Sales Share by Application (2023-2028)
Table 46. Global Porcine Heparin Sodium Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Porcine Heparin Sodium Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Porcine Heparin Sodium Revenue Share by Application (2017-2022)
Table 49. Global Porcine Heparin Sodium Revenue Share by Application (2023-2028)
Table 50. Porcine Heparin Sodium Price by Application (2017-2022) & (US$/Kg)
Table 51. Global Porcine Heparin Sodium Price Forecast by Application (2023-2028) & (US$/Kg)
Table 52. North America Porcine Heparin Sodium Sales by Type (2017-2022) & (Tons)
Table 53. North America Porcine Heparin Sodium Sales by Type (2023-2028) & (Tons)
Table 54. North America Porcine Heparin Sodium Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America Porcine Heparin Sodium Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America Porcine Heparin Sodium Sales by Application (2017-2022) & (Tons)
Table 57. North America Porcine Heparin Sodium Sales by Application (2023-2028) & (Tons)
Table 58. North America Porcine Heparin Sodium Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Porcine Heparin Sodium Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Porcine Heparin Sodium Sales by Country (2017-2022) & (Tons)
Table 61. North America Porcine Heparin Sodium Sales by Country (2023-2028) & (Tons)
Table 62. North America Porcine Heparin Sodium Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Porcine Heparin Sodium Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Porcine Heparin Sodium Sales by Type (2017-2022) & (Tons)
Table 65. Europe Porcine Heparin Sodium Sales by Type (2023-2028) & (Tons)
Table 66. Europe Porcine Heparin Sodium Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe Porcine Heparin Sodium Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe Porcine Heparin Sodium Sales by Application (2017-2022) & (Tons)
Table 69. Europe Porcine Heparin Sodium Sales by Application (2023-2028) & (Tons)
Table 70. Europe Porcine Heparin Sodium Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Porcine Heparin Sodium Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Porcine Heparin Sodium Sales by Country (2017-2022) & (Tons)
Table 73. Europe Porcine Heparin Sodium Sales by Country (2023-2028) & (Tons)
Table 74. Europe Porcine Heparin Sodium Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Porcine Heparin Sodium Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Porcine Heparin Sodium Sales by Type (2017-2022) & (Tons)
Table 77. Asia Pacific Porcine Heparin Sodium Sales by Type (2023-2028) & (Tons)
Table 78. Asia Pacific Porcine Heparin Sodium Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific Porcine Heparin Sodium Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific Porcine Heparin Sodium Sales by Application (2017-2022) & (Tons)
Table 81. Asia Pacific Porcine Heparin Sodium Sales by Application (2023-2028) & (Tons)
Table 82. Asia Pacific Porcine Heparin Sodium Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Porcine Heparin Sodium Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Porcine Heparin Sodium Sales by Region (2017-2022) & (Tons)
Table 85. Asia Pacific Porcine Heparin Sodium Sales by Region (2023-2028) & (Tons)
Table 86. Asia Pacific Porcine Heparin Sodium Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Porcine Heparin Sodium Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Porcine Heparin Sodium Sales by Type (2017-2022) & (Tons)
Table 89. Latin America Porcine Heparin Sodium Sales by Type (2023-2028) & (Tons)
Table 90. Latin America Porcine Heparin Sodium Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America Porcine Heparin Sodium Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America Porcine Heparin Sodium Sales by Application (2017-2022) & (Tons)
Table 93. Latin America Porcine Heparin Sodium Sales by Application (2023-2028) & (Tons)
Table 94. Latin America Porcine Heparin Sodium Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Porcine Heparin Sodium Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Porcine Heparin Sodium Sales by Country (2017-2022) & (Tons)
Table 97. Latin America Porcine Heparin Sodium Sales by Country (2023-2028) & (Tons)
Table 98. Latin America Porcine Heparin Sodium Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Porcine Heparin Sodium Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Porcine Heparin Sodium Sales by Type (2017-2022) & (Tons)
Table 101. Middle East and Africa Porcine Heparin Sodium Sales by Type (2023-2028) & (Tons)
Table 102. Middle East and Africa Porcine Heparin Sodium Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Porcine Heparin Sodium Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Porcine Heparin Sodium Sales by Application (2017-2022) & (Tons)
Table 105. Middle East and Africa Porcine Heparin Sodium Sales by Application (2023-2028) & (Tons)
Table 106. Middle East and Africa Porcine Heparin Sodium Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Porcine Heparin Sodium Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Porcine Heparin Sodium Sales by Country (2017-2022) & (Tons)
Table 109. Middle East and Africa Porcine Heparin Sodium Sales by Country (2023-2028) & (Tons)
Table 110. Middle East and Africa Porcine Heparin Sodium Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Porcine Heparin Sodium Revenue by Country (2023-2028) & (US$ Million)
Table 112. Pfizer Corporation Information
Table 113. Pfizer Description and Major Businesses
Table 114. Pfizer Porcine Heparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 115. Pfizer Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Pfizer Recent Development
Table 117. Bioibérica Corporation Information
Table 118. Bioibérica Description and Major Businesses
Table 119. Bioibérica Porcine Heparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 120. Bioibérica Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Bioibérica Recent Development
Table 122. OPOCRIN Corporation Information
Table 123. OPOCRIN Description and Major Businesses
Table 124. OPOCRIN Porcine Heparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 125. OPOCRIN Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. OPOCRIN Recent Development
Table 127. Aspen Corporation Information
Table 128. Aspen Description and Major Businesses
Table 129. Aspen Porcine Heparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 130. Aspen Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Aspen Recent Development
Table 132. Suanfarma Corporation Information
Table 133. Suanfarma Description and Major Businesses
Table 134. Suanfarma Porcine Heparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 135. Suanfarma Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Suanfarma Recent Development
Table 137. Kraeber & Co GmbH Corporation Information
Table 138. Kraeber & Co GmbH Description and Major Businesses
Table 139. Kraeber & Co GmbH Porcine Heparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 140. Kraeber & Co GmbH Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Kraeber & Co GmbH Recent Development
Table 142. Hepartex Corporation Information
Table 143. Hepartex Description and Major Businesses
Table 144. Hepartex Porcine Heparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 145. Hepartex Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Hepartex Recent Development
Table 147. Hepalink Pharmaceutical Group Corporation Information
Table 148. Hepalink Pharmaceutical Group Description and Major Businesses
Table 149. Hepalink Pharmaceutical Group Porcine Heparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 150. Hepalink Pharmaceutical Group Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Hepalink Pharmaceutical Group Recent Development
Table 152. Nanjing King-friend Corporation Information
Table 153. Nanjing King-friend Description and Major Businesses
Table 154. Nanjing King-friend Porcine Heparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 155. Nanjing King-friend Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Nanjing King-friend Recent Development
Table 157. Haike Group Corporation Information
Table 158. Haike Group Description and Major Businesses
Table 159. Haike Group Porcine Heparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 160. Haike Group Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Haike Group Recent Development
Table 162. Cisen Pharmaceutical Corporation Information
Table 163. Cisen Pharmaceutical Description and Major Businesses
Table 164. Cisen Pharmaceutical Porcine Heparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 165. Cisen Pharmaceutical Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Cisen Pharmaceutical Recent Development
Table 167. Qianhong Biopharma Corporation Information
Table 168. Qianhong Biopharma Description and Major Businesses
Table 169. Qianhong Biopharma Porcine Heparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 170. Qianhong Biopharma Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Qianhong Biopharma Recent Development
Table 172. Xinbai Pharmaceuticals Corporation Information
Table 173. Xinbai Pharmaceuticals Description and Major Businesses
Table 174. Xinbai Pharmaceuticals Porcine Heparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 175. Xinbai Pharmaceuticals Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Xinbai Pharmaceuticals Recent Development
Table 177. Yino Pharma Corporation Information
Table 178. Yino Pharma Description and Major Businesses
Table 179. Yino Pharma Porcine Heparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 180. Yino Pharma Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Yino Pharma Recent Development
Table 182. Deebio Pharmaceutical Corporation Information
Table 183. Deebio Pharmaceutical Description and Major Businesses
Table 184. Deebio Pharmaceutical Porcine Heparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 185. Deebio Pharmaceutical Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Deebio Pharmaceutical Recent Development
Table 187. Tianjin Chasesun Pharmaceutical Corporation Information
Table 188. Tianjin Chasesun Pharmaceutical Description and Major Businesses
Table 189. Tianjin Chasesun Pharmaceutical Porcine Heparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 190. Tianjin Chasesun Pharmaceutical Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. Tianjin Chasesun Pharmaceutical Recent Development
Table 192. Haike Group Corporation Information
Table 193. Haike Group Description and Major Businesses
Table 194. Haike Group Porcine Heparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 195. Haike Group Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 196. Haike Group Recent Development
Table 197. Sheelian Pharmaceutical Corporation Information
Table 198. Sheelian Pharmaceutical Description and Major Businesses
Table 199. Sheelian Pharmaceutical Porcine Heparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 200. Sheelian Pharmaceutical Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 201. Sheelian Pharmaceutical Recent Development
Table 202. Erye Pharmaceutical Corporation Information
Table 203. Erye Pharmaceutical Description and Major Businesses
Table 204. Erye Pharmaceutical Porcine Heparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 205. Erye Pharmaceutical Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 206. Erye Pharmaceutical Recent Development
Table 207. Wanbang Pharmaceutical Corporation Information
Table 208. Wanbang Pharmaceutical Description and Major Businesses
Table 209. Wanbang Pharmaceutical Porcine Heparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 210. Wanbang Pharmaceutical Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 211. Wanbang Pharmaceutical Recent Development
Table 212. Qingdao Kangyuan Pharmaceutical Corporation Information
Table 213. Qingdao Kangyuan Pharmaceutical Description and Major Businesses
Table 214. Qingdao Kangyuan Pharmaceutical Porcine Heparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 215. Qingdao Kangyuan Pharmaceutical Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 216. Qingdao Kangyuan Pharmaceutical Recent Development
Table 217. CSBIO Corporation Information
Table 218. CSBIO Description and Major Businesses
Table 219. CSBIO Porcine Heparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 220. CSBIO Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 221. CSBIO Recent Development
Table 222. Dongcheng Pharmaceutical Corporation Information
Table 223. Dongcheng Pharmaceutical Description and Major Businesses
Table 224. Dongcheng Pharmaceutical Porcine Heparin Sodium Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 225. Dongcheng Pharmaceutical Porcine Heparin Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 226. Dongcheng Pharmaceutical Recent Development
Table 227. Key Raw Materials Lists
Table 228. Raw Materials Key Suppliers Lists
Table 229. Porcine Heparin Sodium Distributors List
Table 230. Porcine Heparin Sodium Customers List
Table 231. Porcine Heparin Sodium Market Trends
Table 232. Porcine Heparin Sodium Market Drivers
Table 233. Porcine Heparin Sodium Market Challenges
Table 234. Porcine Heparin Sodium Market Restraints
Table 235. Research Programs/Design for This Report
Table 236. Key Data Information from Secondary Sources
Table 237. Key Data Information from Primary Sources
List of Figures
Figure 1. Porcine Heparin Sodium Product Picture
Figure 2. Global Porcine Heparin Sodium Market Share by Type in 2021 & 2028
Figure 3. Purity ≥99% Product Picture
Figure 4. Purity ≥99.5% Product Picture
Figure 5. Global Porcine Heparin Sodium Market Share by Application in 2021 & 2028
Figure 6. Injection Solution
Figure 7. Ointment
Figure 8. Others
Figure 9. Porcine Heparin Sodium Report Years Considered
Figure 10. Global Porcine Heparin Sodium Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 11. Global Porcine Heparin Sodium Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 12. Global Porcine Heparin Sodium Production Market Share by Region (2017-2022)
Figure 13. Global Porcine Heparin Sodium Production Market Share by Region (2023-2028)
Figure 14. Porcine Heparin Sodium Production Growth Rate in North America (2017-2028) & (Tons)
Figure 15. Porcine Heparin Sodium Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 16. Porcine Heparin Sodium Production Growth Rate in China (2017-2028) & (Tons)
Figure 17. Global Porcine Heparin Sodium Sales 2017-2028 (Tons)
Figure 18. Global Porcine Heparin Sodium Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 19. Global Porcine Heparin Sodium Revenue 2017-2028 (US$ Million)
Figure 20. Global Porcine Heparin Sodium Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 21. Global Porcine Heparin Sodium Sales Market Share by Region (2017-2022)
Figure 22. Global Porcine Heparin Sodium Sales Market Share by Region (2023-2028)
Figure 23. North America Porcine Heparin Sodium Sales YoY (2017-2028) & (Tons)
Figure 24. North America Porcine Heparin Sodium Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Europe Porcine Heparin Sodium Sales YoY (2017-2028) & (Tons)
Figure 26. Europe Porcine Heparin Sodium Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Porcine Heparin Sodium Sales YoY (2017-2028) & (Tons)
Figure 28. Asia-Pacific Porcine Heparin Sodium Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Latin America Porcine Heparin Sodium Sales YoY (2017-2028) & (Tons)
Figure 30. Latin America Porcine Heparin Sodium Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Middle East & Africa Porcine Heparin Sodium Sales YoY (2017-2028) & (Tons)
Figure 32. Middle East & Africa Porcine Heparin Sodium Revenue YoY (2017-2028) & (US$ Million)
Figure 33. The Porcine Heparin Sodium Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 34. The Top 5 and 10 Largest Manufacturers of Porcine Heparin Sodium in the World: Market Share by Porcine Heparin Sodium Revenue in 2021
Figure 35. Porcine Heparin Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 36. Global Porcine Heparin Sodium Sales Market Share by Type (2017-2028)
Figure 37. Global Porcine Heparin Sodium Revenue Market Share by Type (2017-2028)
Figure 38. Global Porcine Heparin Sodium Sales Market Share by Application (2017-2028)
Figure 39. Global Porcine Heparin Sodium Revenue Market Share by Application (2017-2028)
Figure 40. North America Porcine Heparin Sodium Sales Market Share by Type (2017-2028)
Figure 41. North America Porcine Heparin Sodium Revenue Market Share by Type (2017-2028)
Figure 42. North America Porcine Heparin Sodium Sales Market Share by Application (2017-2028)
Figure 43. North America Porcine Heparin Sodium Revenue Market Share by Application (2017-2028)
Figure 44. North America Porcine Heparin Sodium Sales Share by Country (2017-2028)
Figure 45. North America Porcine Heparin Sodium Revenue Share by Country (2017-2028)
Figure 46. United States Porcine Heparin Sodium Revenue (2017-2028) & (US$ Million)
Figure 47. Canada Porcine Heparin Sodium Revenue (2017-2028) & (US$ Million)
Figure 48. Europe Porcine Heparin Sodium Sales Market Share by Type (2017-2028)
Figure 49. Europe Porcine Heparin Sodium Revenue Market Share by Type (2017-2028)
Figure 50. Europe Porcine Heparin Sodium Sales Market Share by Application (2017-2028)
Figure 51. Europe Porcine Heparin Sodium Revenue Market Share by Application (2017-2028)
Figure 52. Europe Porcine Heparin Sodium Sales Share by Country (2017-2028)
Figure 53. Europe Porcine Heparin Sodium Revenue Share by Country (2017-2028)
Figure 54. Germany Porcine Heparin Sodium Revenue (2017-2028) & (US$ Million)
Figure 55. France Porcine Heparin Sodium Revenue (2017-2028) & (US$ Million)
Figure 56. U.K. Porcine Heparin Sodium Revenue (2017-2028) & (US$ Million)
Figure 57. Italy Porcine Heparin Sodium Revenue (2017-2028) & (US$ Million)
Figure 58. Russia Porcine Heparin Sodium Revenue (2017-2028) & (US$ Million)
Figure 59. Asia Pacific Porcine Heparin Sodium Sales Market Share by Type (2017-2028)
Figure 60. Asia Pacific Porcine Heparin Sodium Revenue Market Share by Type (2017-2028)
Figure 61. Asia Pacific Porcine Heparin Sodium Sales Market Share by Application (2017-2028)
Figure 62. Asia Pacific Porcine Heparin Sodium Revenue Market Share by Application (2017-2028)
Figure 63. Asia Pacific Porcine Heparin Sodium Sales Share by Region (2017-2028)
Figure 64. Asia Pacific Porcine Heparin Sodium Revenue Share by Region (2017-2028)
Figure 65. China Porcine Heparin Sodium Revenue (2017-2028) & (US$ Million)
Figure 66. Japan Porcine Heparin Sodium Revenue (2017-2028) & (US$ Million)
Figure 67. South Korea Porcine Heparin Sodium Revenue (2017-2028) & (US$ Million)
Figure 68. India Porcine Heparin Sodium Revenue (2017-2028) & (US$ Million)
Figure 69. Australia Porcine Heparin Sodium Revenue (2017-2028) & (US$ Million)
Figure 70. China Taiwan Porcine Heparin Sodium Revenue (2017-2028) & (US$ Million)
Figure 71. Indonesia Porcine Heparin Sodium Revenue (2017-2028) & (US$ Million)
Figure 72. Thailand Porcine Heparin Sodium Revenue (2017-2028) & (US$ Million)
Figure 73. Malaysia Porcine Heparin Sodium Revenue (2017-2028) & (US$ Million)
Figure 74. Latin America Porcine Heparin Sodium Sales Market Share by Type (2017-2028)
Figure 75. Latin America Porcine Heparin Sodium Revenue Market Share by Type (2017-2028)
Figure 76. Latin America Porcine Heparin Sodium Sales Market Share by Application (2017-2028)
Figure 77. Latin America Porcine Heparin Sodium Revenue Market Share by Application (2017-2028)
Figure 78. Latin America Porcine Heparin Sodium Sales Share by Country (2017-2028)
Figure 79. Latin America Porcine Heparin Sodium Revenue Share by Country (2017-2028)
Figure 80. Mexico Porcine Heparin Sodium Revenue (2017-2028) & (US$ Million)
Figure 81. Brazil Porcine Heparin Sodium Revenue (2017-2028) & (US$ Million)
Figure 82. Argentina Porcine Heparin Sodium Revenue (2017-2028) & (US$ Million)
Figure 83. Middle East and Africa Porcine Heparin Sodium Sales Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Porcine Heparin Sodium Revenue Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Porcine Heparin Sodium Sales Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Porcine Heparin Sodium Revenue Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Porcine Heparin Sodium Sales Share by Country (2017-2028)
Figure 88. Middle East and Africa Porcine Heparin Sodium Revenue Share by Country (2017-2028)
Figure 89. Turkey Porcine Heparin Sodium Revenue (2017-2028) & (US$ Million)
Figure 90. Saudi Arabia Porcine Heparin Sodium Revenue (2017-2028) & (US$ Million)
Figure 91. UAE Porcine Heparin Sodium Revenue (2017-2028) & (US$ Million)
Figure 92. Porcine Heparin Sodium Value Chain
Figure 93. Porcine Heparin Sodium Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed